# Disease-Specific Meta-Learning Roadmap

## Overview

This document outlines the strategic development of meta-learning capabilities specifically designed to capture alternative splicing patterns induced by mutations and diseases, with particular focus on cancer and neurological disorders.

## Phase 1: Foundation (Current - 7000 Gene Model)

### ✅ Completed Components
- Incremental builder with strategic gene selection
- Gene-aware cross-validation framework
- Basic meta-learning with 3-way classification
- Inference workflow integration

### 🔄 In Progress
- 7000-gene protein-coding model training
- Enhanced uncertainty detection
- Comprehensive evaluation pipeline

## Phase 2: Disease-Specific Enhancements

### 2.1 Mutation-Context Features

**Priority: HIGH**

```python
# New feature categories to implement
mutation_context_features = {
    "genomic_context": [
        "mutation_type",           # SNV, indel, CNV, SV
        "mutation_consequence",    # synonymous, missense, nonsense, splice_site
        "distance_to_splice",      # Distance to nearest canonical splice site
        "splice_site_strength",    # MaxEnt or NNSplice scores
        "conservation_score",      # PhyloP, PhastCons, GERP++
    ],
    "regulatory_context": [
        "enhancer_overlap",        # Overlap with tissue-specific enhancers
        "silencer_overlap",        # Overlap with splicing silencers
        "rbp_binding_sites",       # RNA-binding protein motifs
        "miRNA_targets",           # MicroRNA binding sites
        "chromatin_state",         # H3K4me3, H3K27ac, etc.
    ],
    "expression_context": [
        "tissue_expression",       # GTEx tissue-specific expression
        "disease_expression",      # Disease vs normal expression
        "isoform_usage",          # Tissue-specific isoform patterns
        "co_expression_network",   # Gene co-expression modules
    ]
}
```

### 2.2 Disease-Specific Training Strategies

**Cancer-Focused Meta-Learning:**
```python
cancer_training_strategy = {
    "datasets": {
        "primary": "TCGA_pan_cancer_splice_variants",
        "validation": "ICGC_independent_cohorts", 
        "rare_events": "TARGET_pediatric_cancers"
    },
    "stratification": {
        "by_cancer_type": ["BRCA", "LUAD", "COAD", "GBM", "PRAD"],
        "by_mutation_burden": ["hypermutated", "normal", "hypomutated"],
        "by_splice_pattern": ["exon_skipping", "intron_retention", "alt_splice_sites"]
    },
    "meta_learning_approach": "hierarchical_adaptation"
}
```

**Neurological Disease Focus:**
```python
neuro_training_strategy = {
    "datasets": {
        "ALS": "Answer_ALS_consortium_data",
        "Alzheimer": "ADNI_RNA_seq_data",
        "Parkinson": "PPMI_transcriptome_data",
        "controls": "GTEx_brain_tissues"
    },
    "gene_prioritization": {
        "motor_neuron_genes": ["SOD1", "TARDBP", "FUS", "C9orf72"],
        "synaptic_genes": ["SNCA", "LRRK2", "GBA", "MAPT"],
        "RNA_processing": ["TDP43_targets", "FUS_targets", "hnRNP_network"]
    },
    "temporal_modeling": "disease_progression_aware"
}
```

### 2.3 Advanced Meta-Learning Architectures

**Multi-Task Learning Framework:**
```python
class DiseaseSpecificMetaLearner:
    """
    Multi-task meta-learner for disease-specific splice prediction
    """
    def __init__(self):
        self.base_model = SpliceAI_base
        self.disease_adapters = {
            "cancer": CancerSpecificAdapter(),
            "neurological": NeuroSpecificAdapter(), 
            "rare_disease": RareDiseaseAdapter()
        }
        self.mutation_encoder = MutationContextEncoder()
        self.tissue_encoder = TissueSpecificEncoder()
    
    def predict(self, sequence, mutation_context, disease_type):
        # Base splice prediction
        base_pred = self.base_model(sequence)
        
        # Mutation context encoding
        mut_features = self.mutation_encoder(mutation_context)
        
        # Disease-specific adaptation
        adapter = self.disease_adapters[disease_type]
        adapted_pred = adapter(base_pred, mut_features)
        
        return adapted_pred
```

## Phase 3: Validation & Clinical Translation

### 3.1 Benchmarking Framework

**Validation Datasets:**
```python
validation_framework = {
    "known_pathogenic": {
        "source": "ClinVar_pathogenic_splice_variants",
        "metrics": ["sensitivity", "specificity", "PPV", "NPV"]
    },
    "functional_validation": {
        "source": "minigene_assay_results",
        "metrics": ["correlation_with_PSI", "direction_agreement"]
    },
    "clinical_cohorts": {
        "cancer": "TCGA_validation_set",
        "neurological": "independent_ALS_cohort",
        "metrics": ["survival_prediction", "disease_progression"]
    }
}
```

### 3.2 Interpretability & Clinical Utility

**SHAP-Based Disease Interpretation:**
```python
class DiseaseSpecificSHAP:
    """
    Disease-specific SHAP analysis for clinical interpretation
    """
    def explain_cancer_splice_variant(self, variant, patient_context):
        # Generate SHAP values for cancer-specific features
        shap_values = self.compute_shap(variant, "cancer")
        
        # Clinical interpretation
        interpretation = {
            "splice_disruption_score": shap_values["splice_strength"],
            "oncogene_impact": shap_values["oncogene_features"],
            "tumor_suppressor_impact": shap_values["tsg_features"],
            "therapeutic_implications": self.get_drug_targets(variant)
        }
        return interpretation
```

## Phase 4: Integration with Case Studies

### 4.1 VCF-to-Alternative-Splice Pipeline Enhancement

**Disease-Aware Processing:**
```python
class DiseaseAwareVCFProcessor:
    """
    Enhanced VCF processor with disease-specific annotations
    """
    def process_cancer_vcf(self, vcf_path, cancer_type):
        # Standard VCF processing
        variants = self.load_vcf(vcf_path)
        
        # Cancer-specific annotations
        annotated_variants = self.add_cancer_annotations(
            variants, cancer_type
        )
        
        # Disease-specific meta-model prediction
        splice_predictions = self.disease_meta_model.predict(
            annotated_variants, disease_type="cancer"
        )
        
        return splice_predictions
```

### 4.2 Clinical Report Generation

**Automated Clinical Interpretation:**
```python
class ClinicalSpliceReport:
    """
    Generate clinical reports for splice variant interpretation
    """
    def generate_cancer_report(self, patient_variants, cancer_type):
        report = {
            "patient_id": patient_variants["sample_id"],
            "cancer_type": cancer_type,
            "splice_variants": [],
            "therapeutic_implications": [],
            "prognosis_markers": []
        }
        
        for variant in patient_variants["variants"]:
            splice_impact = self.assess_splice_impact(variant, cancer_type)
            if splice_impact["pathogenicity"] > 0.8:
                report["splice_variants"].append({
                    "variant": variant,
                    "gene": variant["gene"],
                    "splice_impact": splice_impact,
                    "clinical_significance": self.get_clinical_significance(variant),
                    "therapeutic_options": self.get_therapeutic_options(variant)
                })
        
        return report
```

## Implementation Timeline

### Months 1-2: Foundation Enhancement
- [ ] Complete 7000-gene model training
- [ ] Implement mutation-context feature extraction
- [ ] Develop disease-specific data loaders

### Months 3-4: Disease-Specific Models
- [ ] Train cancer-specific meta-learner
- [ ] Train neurological disease meta-learner
- [ ] Implement multi-task learning framework

### Months 5-6: Validation & Integration
- [ ] Comprehensive benchmarking on clinical datasets
- [ ] Integration with case study workflows
- [ ] Clinical interpretation tools

### Months 7-8: Clinical Translation
- [ ] Clinical report generation
- [ ] Therapeutic implication analysis
- [ ] Collaboration with clinical partners

## Success Metrics

### Technical Metrics
- **Splice Prediction Accuracy**: >90% on known pathogenic variants
- **Disease Specificity**: Significant improvement over generic models
- **Generalization**: Consistent performance across cancer types/neurological diseases

### Clinical Metrics
- **Clinical Utility**: Actionable findings in >20% of cases
- **Therapeutic Relevance**: Identification of targetable splice variants
- **Prognostic Value**: Correlation with patient outcomes

### Research Impact
- **Publication Potential**: High-impact journal publications
- **Clinical Adoption**: Integration into clinical workflows
- **Community Impact**: Open-source tools for research community

## Resource Requirements

### Computational Resources
- **Training**: 4-8 GPUs for 2-4 weeks per disease-specific model
- **Inference**: CPU-based inference for clinical deployment
- **Storage**: 10-50TB for multi-disease training datasets

### Data Requirements
- **Cancer Data**: TCGA, ICGC, TARGET (>10,000 samples)
- **Neurological Data**: ALS, Alzheimer's, Parkinson's cohorts (>5,000 samples)
- **Validation Data**: Independent clinical cohorts (>2,000 samples)

### Personnel
- **Computational Biologist**: Disease-specific model development
- **Clinical Collaborator**: Clinical validation and interpretation
- **Software Engineer**: Clinical tool development and deployment








